- What This Credential Actually Is
- Who Certifies It and Why That Matters
- Who Can Sit for It
- Exam Format and Scoring
- The 17 Content Areas
- Fees and Deadlines
- AOBIM Oncology vs. ABIM Medical Oncology
- Keeping the Certificate: OCC
- Sequencing Your Preparation
- Where the Credential Fits in Practice
- Frequently Asked Questions
- This is the AOBIM subspecialty certification in Oncology, not ABIM Medical Oncology or a combined hematology-oncology exam.
- The initial exam has 300 multiple-choice questions over seven hours; a scaled score of 500 on the 200-800 scale passes.
- Hematologic malignancies (15-19%) and Genitourinary tumors (10-14%) are the two heaviest content areas.
- Initial exam fee is $800; filing late adds $240, for a $1,040 total.
What This Credential Actually Is
"Oncology" is an overloaded word. Patients use it for a field of medicine, residents use it for a rotation, and several credentialing bodies use it in the names of their certificates. On this site, the term means one thing: the physician subspecialty certification in Oncology administered through the American Osteopathic Board of Internal Medicine (AOBIM), with certification approval through the American Osteopathic Association (AOA).
If you landed here searching for a definition of the field itself, our general explainers on what oncology is and oncology meaning cover that ground. This article is narrower. It answers the question a physician asks when they type "what is a oncology" into a search bar: what is this certificate, who earns it, and what does earning it involve?
In short, it is a board certification for osteopathic internists who have completed oncology subspecialty training and want formal recognition of that expertise. It is a separate credential from the primary internal medicine certification, and it has its own eligibility pathway, its own written examination, and its own maintenance requirements.
Who Certifies It and Why That Matters
AOBIM sets the standards for osteopathic internal medicine and its subspecialties, and the AOA provides the certification approval framework. For candidates, this has practical consequences. The exam outline you study from is AOBIM's, the policies you follow are AOBIM's, and the maintenance system you enter after passing is Osteopathic Continuous Certification rather than an allopathic maintenance program.
That is also why generic oncology board review material can mislead. A resource built around a different blueprint may overweight topics that AOBIM treats lightly, or underweight areas AOBIM tests heavily. We cover how the two pathways differ in more detail below, and our overview of what oncology certification is frames the broader landscape.
Who Can Sit for It
Eligibility is built around three things: your primary certification, your training, and your standing. The requirements include:
- AOA board certification in internal medicine
- Two years of an ACGME-accredited or AOA-recognized Oncology or Hematology/Oncology fellowship
- An active medical license
- Ethical standing
- A completed application with program-director verification
One nuance deserves attention. A qualifying three-year combined or separate hematology/oncology training route can support applications for the separate Hematology and Oncology examinations. In other words, a combined fellowship does not mean a combined exam; the certificates remain distinct, and each is earned through its own written examination.
Because eligibility details and documentation expectations can change, confirm them against the official AOBIM pages before filing. Our Oncology requirements guide walks through the prerequisites step by step, and the oncology training overview explains how fellowship choices connect to eligibility.
Exam Format and Scoring
The initial written examination contains 300 multiple-choice questions and lasts seven hours. That is a long sitting, and stamina is part of the test. A candidate who knows the material but has never practiced sustained question work can fade in the final third.
How the passing score works
Passing requires a scaled score of at least 500 on the AOA 200-800 scale. This is the single most misunderstood point about the exam. A scaled score of 500 is not 500 out of 800 points, and it is not a raw percentage of questions answered correctly. Scaling converts raw performance into a reporting scale so that results remain comparable across forms. Do not try to reverse-engineer a "percent correct" target from the number 500. Our passing score breakdown explains what the scale does and does not tell you.
Question style
Expect clinical-vignette multiple-choice items that test management decisions, recognition of syndromes, interpretation of toxicity, and understanding of treatment principles across tumor types. The format rewards candidates who can move from a presentation to the next best step, not just those who can recite staging tables. For a candid read on difficulty, see how hard the Oncology exam is, and for outcome data context, our pass rate article explains what is and is not publicly known.
Score audit
Candidates may request an optional score audit for $200. The request must be made within one month of receiving results, so decide quickly if you intend to use it.
The 17 Content Areas
AOBIM publishes percentage ranges for each content area. Treat these as ranges, not as fixed question counts, and avoid collapsing them into midpoints. The ranges tell you where a disproportionate share of the exam lives.
| Content Area | Official Range |
|---|---|
| Hematologic malignancies | 15-19% |
| Genitourinary tumors | 10-14% |
| Gastrointestinal tumors | 6-10% |
| Chemotherapy toxicity | 6-10% |
| Breast tumors | 5-9% |
| Supportive care/palliative/ethics | 5-9% |
| Thoracic tumors | 4-8% |
| Paraneoplastic syndromes | 4-8% |
| Gynecologic tumors | 3-7% |
| Pharmacology/cancer biology/cancer genetics | 2-6% |
| Pancreatic/liver cancer | 2-6% |
| Prevention/screening | 2-6% |
| Skin cancer | 1-5% |
| Head and neck cancer | 1-5% |
| Bone/soft tissue/sarcoma | 1-5% |
| Opportunistic infection | 1-4% |
| Cancer trials | 1-3% |
Hematologic Malignancies (15-19%)
The largest area, and the one where depth pays off most. Candidates should be able to move fluidly between diagnosis, risk stratification, and treatment selection.
- Leukemias, lymphomas, and plasma cell disorders as distinct management problems
- Interpreting presentations, laboratory findings, and disease complications
- Therapy-related toxicities specific to hematologic regimens
Genitourinary Tumors (10-14%)
The second-largest area is large enough to be a study priority of its own rather than a footnote to solid tumors.
- Prostate, bladder, kidney, and testicular malignancies
- Staging-driven treatment decisions and systemic therapy selection
- Surveillance and follow-up principles
Chemotherapy Toxicity and Paraneoplastic Syndromes
Together these two areas carry a meaningful share of the exam (6-10% and 4-8%) and reward pattern recognition over memorization.
- Recognizing organ-specific drug toxicity and knowing the response
- Identifying paraneoplastic presentations and linking them to the underlying malignancy
- Recognizing oncologic emergencies that arise from treatment or disease
Smaller areas such as cancer trials (1-3%) or opportunistic infection (1-4%) are easy to neglect, but they are often the quickest points to secure because the tested concepts are bounded. Our full breakdown in Oncology Exam Domains: Complete Guide to All 17 Content Areas goes through each area in detail, and the Oncology cheat sheet condenses high-yield facts for late-stage review.
Fees and Deadlines
| Item | Amount (USD) |
|---|---|
| Initial examination | $800 |
| Late surcharge | $240 |
| Examination plus late surcharge | $1,040 |
| Optional score audit | $200 |
The $1,040 figure is simply the exam fee plus the late surcharge. Filing on time saves $240, which is the cheapest "study resource" you will ever buy. If you request a score audit, remember the one-month window after results are released. Beyond the exam fee itself, budget for study materials and any OCC costs later; our certification cost breakdown lays out the full picture, and exam dates and deadlines covers scheduling logistics. Always verify current amounts and dates on the official AOBIM written-exam page before paying.
AOBIM Oncology vs. ABIM Medical Oncology
Candidates frequently conflate these, and search results make it worse. They are different credentials from different certifying bodies, with different blueprints and different maintenance systems.
| Dimension | AOBIM Oncology (this site) | ABIM Medical Oncology |
|---|---|---|
| Certifying body | American Osteopathic Board of Internal Medicine | American Board of Internal Medicine |
| Approval framework | AOA certification approval | Separate ABIM process |
| Maintenance | Osteopathic Continuous Certification (OCC) | Its own maintenance program |
| Exam blueprint | AOBIM 17-area outline with published ranges | Its own blueprint; do not substitute |
Keeping the Certificate: OCC
Certification has a ten-year term, conditional on participation in Osteopathic Continuous Certification. For the 2025-2027 cycle, time-limited diplomates need:
- 60 CME credits over three years, including 15 Category 1 and/or Category 1-A credits
- One quality-improvement activity attestation per three-year cycle
- Active licensure
Oncology remains on the remotely proctored subspecialty OCC examination route, offered annually in August. Diplomates may begin that examination two years before certificate expiration, and a successful early renewal extends from the existing certificate's expiration date, so testing early does not cost you remaining time on your current certificate.
Keep this distinct from the primary internal medicine longitudinal assessment. The subspecialty OCC exam route is its own component, and conflating the two is a common planning error. Two practical consequences: first, start tracking CME and your quality-improvement attestation from day one rather than assembling them near a deadline; second, decide early whether you will use the early-testing window, since it spreads the workload over a longer horizon.
Sequencing Your Preparation
Generic study advice is plentiful; what matters here is how the blueprint should shape your calendar. Work from weight and difficulty, not from the order of a textbook. For a fuller plan, see our Oncology study guide. The skeleton below is tied directly to the blueprint.
Anchor the heavy hitters
- Hematologic malignancies (15-19%) first, since it is the largest single area
- Genitourinary tumors (10-14%) immediately after
Solid tumors and treatment effects
- Gastrointestinal, breast, thoracic, and gynecologic tumors
- Chemotherapy toxicity and paraneoplastic syndromes alongside them, because the cases overlap
Sweep the small areas and simulate
- Skin, head and neck, sarcoma, infection, trials, and prevention/screening
- Full-length mixed question sets to build seven-hour stamina
Practice with original questions and explanations mapped to the AOBIM Oncology outline, not recycled questions from another certification. You can try that approach on our main practice test site, and the question bank is organized around the AOBIM content areas rather than a generic oncology curriculum.
Where the Credential Fits in Practice
Subspecialty certification signals verified expertise to the settings that rely on oncology physicians: hospital cancer programs, community oncology practices, academic centers, and health systems building multidisciplinary teams. Credentialing and privileging committees commonly look for board certification in the subspecialty, so the certificate can influence which positions and privileges are open to you.
We deliberately avoid quoting compensation figures here, because numbers vary widely by region, setting, and practice model and are easy to misstate. For a measured discussion, see our salary guide, our overview of oncology jobs, and the ROI analysis that weighs cost against career benefit.
Frequently Asked Questions
It is the AOBIM physician subspecialty certification in Oncology, approved through the AOA, earned by passing a 300-question written examination after qualifying fellowship training.
No. It is a separate credential from a different certifying body with its own blueprint, fees, and maintenance. Do not substitute one pathway's details for the other.
A scaled score of at least 500 on the AOA 200-800 scale. That is not a raw percentage of correct answers, so avoid converting it into a target percent correct.
The initial examination is $800. A late surcharge of $240 brings the total to $1,040, and an optional score audit costs $200, which must be requested within one month of results.
Certification has a ten-year term, maintained through Osteopathic Continuous Certification. Oncology uses the remotely proctored subspecialty OCC exam route, offered annually in August, alongside CME, quality-improvement, and licensure requirements.
For the official word on current policies, always confirm details on the AOBIM Oncology pages before filing or scheduling, then build your preparation around the published 17-area outline.